Cost-effectiveness of non-surgical periodontal therapy for patients with type 2 diabetes in the UK

Journal of Clinical Periodontology
Josephine Solowiej-WedderburnMark Pennington

Abstract

Periodontal therapy has been shown to reduce glycated haemoglobin in patients with diabetes, although considerable uncertainty remains regarding the sustainability of such changes. We evaluate the cost-effectiveness of non-surgical periodontal therapy and rigorous maintenance treatment in patients with type 2 diabetes and periodontitis from a provider perspective in the UK. Lifetime costs relating to periodontal treatment were modelled for a cohort of patients with type 2 diabetes. The projected lifetime impact of changes in glycated haemoglobin on diabetes treatment costs and quality adjusted life expectancy were estimated from a published simulation model. Costs and outcomes were combined to estimate the Incremental Cost-Effectiveness Ratio for periodontal therapy in patients with type 2 diabetes. The Incremental Cost-Effectiveness Ratio was £28,000 per Quality Adjusted Life-Year for a man aged 58 with glycated haemoglobin of 7%-7.9%. The results were particularly sensitive to assumptions on the impact of periodontal therapy on glycated haemoglobin, the proportion of patients who comply with maintenance therapy and the proportion of compliant patients who respond to treatment. Assuming improvements in glycated haemoglobin can...Continue Reading

References

May 1, 1978·Journal of Periodontology·L Hirschfeld, B Wasserman
May 1, 1979·Journal of Periodontology·W BeckerB E Becker
Jul 15, 1990·Annals of Internal Medicine·A S Detsky, I G Naglie
May 1, 1988·Journal of Periodontology·C L NabersS Canales
Jun 10, 1993·The New England Journal of Medicine·D M Nathan
Nov 1, 1987·Journal of Dental Research·A A Antczak-Bouckoms, M C Weinstein
Jun 12, 2004·Journal of Clinical Periodontology·Øystein FardalGerard J Linden
May 27, 2008·Practical Neurology·Yolanda Bravo Vergel, Mark Sculpher
Sep 5, 2008·PharmacoEconomics·Christopher McCabeAnthony J Culyer
Feb 4, 2009·Journal of Periodontology·John A MartinCarl F Loeb
Jul 2, 2009·Journal of Clinical Periodontology·Bernadette PretzlPeter Eickholz
Feb 16, 2010·Journal of Periodontology·John A MartinPaul A Levi
Dec 8, 2010·Periodontology 2000·Peter A HeasmanMark W Pennington
Feb 24, 2011·Journal of Clinical Periodontology·Mervyn Cher-Hui NgYiong Huak Chan
May 11, 2011·Journal of Clinical Periodontology·Mark PenningtonChris Vernazza
Mar 15, 2012·Journal of Periodontology·Øystein FardalGerard J Linden
May 3, 2013·Journal of Clinical Periodontology·Iain L C ChappleUNKNOWN Working group 2 of joint EFP/AAP workshop
May 3, 2013·Journal of Clinical Periodontology·Wenche S BorgnakkeRobert J Genco
Feb 18, 2014·Journal of Clinical Periodontology·Christoph A RamseierGiovanni E Salvi
Nov 28, 2014·Journal of Periodontology·Dina GarciaChristopher Okunseri
Jan 27, 2016·Journal of Clinical Periodontology·Sabrina Lill BusetNicola U Zitzmann

❮ Previous
Next ❯

Citations

Apr 16, 2020·Brazilian Oral Research·Ricardo Guimarães FischerMagda Feres
Jan 21, 2021·Journal of Clinical Medicine·Caroline SekundoStefan Listl
Oct 26, 2020·BMJ Open Diabetes Research & Care·Kirsten P J SmitsOlivier Kalmus
Jan 9, 2021·Clinical Oral Investigations·Christelle DarnaudMaria Clotilde Carra
Mar 27, 2021·Journal of Clinical Periodontology·John Rong Hao TaySharon Hui Xuan Tan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.